Q-Line Biotech Limited IPO (QLINE)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Q-Line Biotech Limited IPO?
The Q-Line Biotech Limited IPO price band is Rs.326 to Rs.343 per share.
When does the Q-Line Biotech Limited IPO open and close?
Bidding opens 21 May 2026 and closes 25 May 2026.
Is the Q-Line Biotech Limited IPO a mainboard or SME issue?
Q-Line Biotech Limited is an SME IPO, listing on NSE Emerge.
When did the Q-Line Biotech Limited IPO list?
Q-Line Biotech Limited listed on 29 May 2026.
Does this page show the grey market premium (GMP) for Q-Line Biotech Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Q-Line Biotech Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.